Teva Pharmaceutical Industries Ltd., the world’s biggest seller of generics medicines, named Kare Schultz as its new chief executive, choosing an industry veteran to navigate a series of daunting challenges, from falling drug prices to the company’s high debt. The appointment of Mr. Schultz, a Dane, ends a monthslong period during which Teva had no permanent top executive. It recently shuffled its board and is shedding assets,...

Source: Wall Street Journal September 11, 2017 07:30 UTC